OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Association between sodium–glucose co-transporter 2 inhibitors and risk of psoriasis in patients with diabetes mellitus: a nationwide population-based cohort study
Sheng‐Hsiang Ma, Chun‐Ying Wu, Ying‐Syuan Lyu, et al.
Clinical and Experimental Dermatology (2022) Vol. 47, Iss. 12, pp. 2242-2250
Open Access | Times Cited: 7
Sheng‐Hsiang Ma, Chun‐Ying Wu, Ying‐Syuan Lyu, et al.
Clinical and Experimental Dermatology (2022) Vol. 47, Iss. 12, pp. 2242-2250
Open Access | Times Cited: 7
Showing 7 citing articles:
Effects of sodium-glucose cotransporter-2 inhibitors on inflammatory skin diseases in patients with type 2 diabetes
Kevin Sheng‐Kai, Serena Yun‐Chen Tsai, Allison Holt, et al.
Journal of the American Academy of Dermatology (2024)
Closed Access | Times Cited: 3
Kevin Sheng‐Kai, Serena Yun‐Chen Tsai, Allison Holt, et al.
Journal of the American Academy of Dermatology (2024)
Closed Access | Times Cited: 3
Skin-Related Adverse Reactions Induced by Oral Antidiabetic Drugs—A Review of Literature and Case Reports
Justyna Kowalska, Dorota Wrześniok
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 847-847
Open Access | Times Cited: 2
Justyna Kowalska, Dorota Wrześniok
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 847-847
Open Access | Times Cited: 2
Molecular mechanisms and drug therapy of metabolism disorders in psoriasis
Yanyang Liang, Ying Wang, Aihong Peng, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 2
Yanyang Liang, Ying Wang, Aihong Peng, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 2
SGLT2 inhibition: A possible mode-of-action for inflammatory skin diseases?
Susanne Kammerer
(2024)
Closed Access
Susanne Kammerer
(2024)
Closed Access
Cutaneous Adverse Drug Reactions Associated with SGLT2 Inhibitors
Alexandra Laura Mederle, Patrick Dumitrescu, Claudia Borza, et al.
Journal of Clinical Medicine (2024) Vol. 14, Iss. 1, pp. 188-188
Open Access
Alexandra Laura Mederle, Patrick Dumitrescu, Claudia Borza, et al.
Journal of Clinical Medicine (2024) Vol. 14, Iss. 1, pp. 188-188
Open Access
Metabolic syndrome and psoriatic arthritis: the role of weight loss as a disease-modifying therapy
J. Williams, Ryan Hum, Kira Rogers, et al.
Therapeutic Advances in Musculoskeletal Disease (2024) Vol. 16
Open Access
J. Williams, Ryan Hum, Kira Rogers, et al.
Therapeutic Advances in Musculoskeletal Disease (2024) Vol. 16
Open Access
Psoriasiform lesions as a side effect of SGLT-2 therapy
Jakub Krzysztof Gałązka, Łukasz Domagalski, Piotr Homa, et al.
Quality in Sport (2023) Vol. 9, Iss. 1, pp. 35-39
Open Access | Times Cited: 1
Jakub Krzysztof Gałązka, Łukasz Domagalski, Piotr Homa, et al.
Quality in Sport (2023) Vol. 9, Iss. 1, pp. 35-39
Open Access | Times Cited: 1
